Finalist
Innovative Trials
Summary of work
Founded in 2010, Innovative Trials serves as a pioneering patient recruitment enterprise that seeks to revolutionise clinical trial patient recruitment. This endeavour is rooted in the observation of a void within the Patient Recruitment sector, spurring a commitment to reintegrating patients into the core of clinical trials. The company’s fundamental mission is to expedite clinical development, broaden patient access to life-enhancing treatments, and foster community engagement. Operating in more than 70 countries, Innovative Trials employs around 65 clinical experts to assist pharmaceuticals, biotech firms, and CROs grappling with intricate patient recruitment demands across 25+ therapy domains, spanning 90+ conditions and over 300 clinical trials. In 2022 and 2023, the company witnessed remarkable growth in various dimensions. This involved achieving a 32% surge in net revenue and a 45% increase in operating margin during 2022 compared to the preceding year. Moreover, employee numbers expanded by 21% since 2021. These achievements were propelled by the establishment of a US office in 2022, the recruitment of a Vice President of Commercial, and the introduction of the Navigator service. These strategic moves are expected to serve as the foundation for sustained expansion in 2023, as evidenced by the promising Q1 2023 performance.
Judges' comments
Innovative Trials demonstrated evidence of client delivery, as having impact and client satisfaction was measured and significant improvement was shown year on year. They have a good people approach. Overall, they are a different agency offering, with good growth and clear idea for strategic development.
